Bank of Montreal’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,027
| Closed | -$67.9K | – | 3927 |
|
|
2024
Q3 | $67.9K | Sell |
8,027
-86,439
| -92% | -$715K | ﹤0.01% | 3345 |
|
|
2024
Q2 | $926K | Buy |
94,466
+77,909
| +471% | +$950K | ﹤0.01% | 2070 |
|
|
2024
Q1 | $253K | Sell |
16,557
-5,748
| -26% | -$104K | ﹤0.01% | 2891 |
|
|
2023
Q4 | $493K | Buy |
22,305
+7,931
| +55% | +$146K | ﹤0.01% | 2515 |
|
|
2023
Q3 | $306K | Sell |
14,374
-6,643
| -32% | -$155K | ﹤0.01% | 2791 |
|
|
2023
Q2 | $533K | Sell |
21,017
-117,309
| -85% | -$2.95M | ﹤0.01% | 2554 |
|
|
2023
Q1 | $4.38M | Buy |
138,326
+27,478
| +25% | +$735K | ﹤0.01% | 1292 |
|
|
2022
Q4 | $2.62M | Buy |
110,848
+65,262
| +143% | +$1.76M | ﹤0.01% | 1657 |
|
|
2022
Q3 | $1.21K | Sell |
45,586
-544,211
| -92% | -$19.1M | ﹤0.01% | 2064 |
|
|
2022
Q2 | $22.1K | Sell |
589,797
-1,511,048
| -72% | -$64.2M | 0.01% | 722 |
|
|
2022
Q1 | $154M | Sell |
2,100,845
-1,265,408
| -38% | -$91.2M | 0.07% | 194 |
|
|
2021
Q4 | $318M | Buy |
3,366,253
+1,057,783
| +46% | +$126M | 0.17% | 112 |
|
|
2021
Q3 | $301M | Buy |
2,308,470
+1,467,509
| +175% | +$214M | 0.14% | 128 |
|
|
2021
Q2 | $146M | Buy |
840,961
+678,678
| +418% | +$110M | 0.07% | 230 |
|
|
2021
Q1 | $29.6M | Buy |
162,283
+54,121
| +50% | +$12.6M | 0.02% | 554 |
|
|
2020
Q4 | $23.9M | Buy |
108,162
+31,254
| +41% | +$6.36M | 0.02% | 637 |
|
|
2020
Q3 | $16.7M | Buy |
76,908
+44,699
| +139% | +$9.47M | 0.01% | 648 |
|
|
2020
Q2 | $7.36M | Sell |
32,209
-24,157
| -43% | -$4.23M | 0.01% | 989 |
|
|
2020
Q1 | $8.98M | Sell |
56,366
-30,609
| -35% | -$3.56M | 0.01% | 739 |
|
|
2019
Q4 | $7.28M | Buy |
86,975
+42,936
| +97% | +$3.27M | 0.01% | 1146 |
|
|
2019
Q3 | $2.98M | Sell |
44,039
-4,929
| -10% | -$324K | ﹤0.01% | 1436 |
|
|
2019
Q2 | $3.25M | Buy |
48,968
+7,149
| +17% | +$417K | ﹤0.01% | 1420 |
|
|
2019
Q1 | $2.33M | Sell |
41,819
-1,939
| -4% | -$118K | ﹤0.01% | 1583 |
|
|
2018
Q4 | $2.17M | Buy |
43,758
+23,193
| +113% | +$1.42M | ﹤0.01% | 1477 |
|
|
2018
Q3 | $1.78M | Buy |
20,565
+5,719
| +39% | +$408K | ﹤0.01% | 1733 |
|
|
2018
Q2 | $862K | Sell |
14,846
-9,194
| -38% | -$449K | ﹤0.01% | 2077 |
|
|
2018
Q1 | $969K | Buy |
24,040
+925
| +4% | +$34.9K | ﹤0.01% | 1934 |
|
|
2017
Q4 | $805K | Buy |
23,115
+14,356
| +164% | +$477K | ﹤0.01% | 2053 |
|
|
2017
Q3 | $290K | Buy |
8,759
+5,243
| +149% | +$172K | ﹤0.01% | 2503 |
|
|
2017
Q2 | $123K | Buy |
3,516
+2,397
| +214% | +$69.8K | ﹤0.01% | 2893 |
|
|
2017
Q1 | $28K | Hold |
1,119
| – | – | ﹤0.01% | 3269 |
|
|
2016
Q4 | $21K | Hold |
1,119
| – | – | ﹤0.01% | 3391 |
|
|
2016
Q3 | $20K | Hold |
1,119
| – | – | ﹤0.01% | 3350 |
|
|
2016
Q2 | $18K | Sell |
1,119
-11,751
| -91% | -$137K | ﹤0.01% | 3427 |
|
|
2016
Q1 | $124K | Buy |
+12,870
| New | +$183K | ﹤0.01% | 2704 |
|
Other funds holding TDOC
MRCP
Bank of Montreal's TDOC Position: Q4 2024 in Review
Bank of Montreal sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 8,027 shares — an estimated $67.9K sold.
Bank of Montreal first reported a position in TDOC in Q1 2016 and held it in 35 quarters. The position peaked at $318M in Q4 2021. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.
- Bank of Montreal reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
- Bank of Montreal sold 8,027 Teladoc Health shares in Q4 2024, an estimated $67.9K.
- Bank of Montreal first reported a position in Teladoc Health in Q1 2016 and held it in 35 quarters.
- Bank of Montreal's Teladoc Health position peaked at $318M in Q4 2021.
- 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.
Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.